first week on semaglutide for weight loss GLP-1: How Your Body May Respond What to Expect During the

Latest Clinical Data on Higher Doses The 2025 STEP UP phase 3b trial evaluated semaglutide at both 7.2 mg and 2.4 mg weekly doses versus placebo in people with obesity who did not have diabetes

Improved Liver Function

& Pocock, R

In simplistic terms, oxidative stress occurs when we dont have sufficient antioxidants in the body and unstable free radicals begin to damage our organs and genetic material

For the millions of Americans and people worldwide struggling with severe obesity and related health complications, retatrutide represents hope for a truly transformative treatment optionone that could fundamentally change the trajectory of the global obesity epidemic

The FDA placed 19 peptides on the Category 2 list, meaning pharmacies could no longer produce these compounds legally